Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormonesensitive early breast cancer: a case study

BACKGROUND: In order to reduce the risk of recurrence, adjuvant treatment with an aromatase inhibitor (AI) is recommended for postmenopausal women following surgery for hormone receptor-positive breast cancer. AIs are associated with improved disease-free survival compared with tamoxifen. The advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryce, Jane, Bauer, Martina, Hadji, Peyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345876/
https://www.ncbi.nlm.nih.gov/pubmed/22570564
http://dx.doi.org/10.2147/CMAR.S29448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345876/
https://www.ncbi.nlm.nih.gov/pubmed/22570564
http://dx.doi.org/10.2147/CMAR.S29448

Ejemplares similares